326 related articles for article (PubMed ID: 24376670)
1. In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.
de Macedo-Silva ST; Urbina JA; de Souza W; Rodrigues JC
PLoS One; 2013; 8(12):e83247. PubMed ID: 24376670
[TBL] [Abstract][Full Text] [Related]
2. Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.
de Macedo-Silva ST; Visbal G; Urbina JA; de Souza W; Rodrigues JC
Antimicrob Agents Chemother; 2015 Oct; 59(10):6402-18. PubMed ID: 26239973
[TBL] [Abstract][Full Text] [Related]
3. In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis.
Teixeira de Macedo Silva S; Visbal G; Lima Prado Godinho J; Urbina JA; de Souza W; Cola Fernandes Rodrigues J
J Antimicrob Chemother; 2018 Sep; 73(9):2360-2373. PubMed ID: 29982734
[TBL] [Abstract][Full Text] [Related]
4. A novel alkyl phosphocholine-dinitroaniline hybrid molecule exhibits biological activity in vitro against Leishmania amazonensis.
Godinho JL; Georgikopoulou K; Calogeropoulou T; de Souza W; Rodrigues JC
Exp Parasitol; 2013 Sep; 135(1):153-65. PubMed ID: 23845259
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis.
Rodrigues JC; Urbina JA; de Souza W
Exp Parasitol; 2005 Dec; 111(4):230-8. PubMed ID: 16198340
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.
Fernandes Rodrigues JC; Concepcion JL; Rodrigues C; Caldera A; Urbina JA; de Souza W
Antimicrob Agents Chemother; 2008 Nov; 52(11):4098-114. PubMed ID: 18765694
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis.
Inacio JD; Canto-Cavalheiro MM; Menna-Barreto RF; Almeida-Amaral EE
Exp Parasitol; 2012 Oct; 132(2):151-5. PubMed ID: 22735546
[TBL] [Abstract][Full Text] [Related]
8. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.
Rangel H; Dagger F; Hernandez A; Liendo A; Urbina JA
Antimicrob Agents Chemother; 1996 Dec; 40(12):2785-91. PubMed ID: 9124841
[TBL] [Abstract][Full Text] [Related]
9. The stepwise selection for ketoconazole resistance induces upregulation of C14-demethylase (CYP51) in Leishmania amazonensis.
Andrade-Neto VV; Matos-Guedes HL; Gomes DC; Canto-Cavalheiro MM; Rossi-Bergmann B; Torres-Santos EC
Mem Inst Oswaldo Cruz; 2012 May; 107(3):416-9. PubMed ID: 22510839
[TBL] [Abstract][Full Text] [Related]
10. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
[TBL] [Abstract][Full Text] [Related]
11. Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.
Pandharkar T; Zhu X; Mathur R; Jiang J; Schmittgen TD; Shaha C; Werbovetz KA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4682-9. PubMed ID: 24890590
[TBL] [Abstract][Full Text] [Related]
12. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
Beach DH; Goad LJ; Holz GG
Mol Biochem Parasitol; 1988 Nov; 31(2):149-62. PubMed ID: 2847043
[TBL] [Abstract][Full Text] [Related]
13. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Activity of Novel Zinc-Itraconazole Complexes in Protozoan Parasites and
Azevedo-França JA; Granado R; de Macedo Silva ST; Santos-Silva GD; Scapin S; Borba-Santos LP; Rozental S; de Souza W; Martins-Duarte ÉS; Barrias E; Rodrigues JCF; Navarro M
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152072
[TBL] [Abstract][Full Text] [Related]
16. Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway.
Feng M; Jin Y; Yang S; Joachim AM; Ning Y; Mori-Quiroz LM; Fromm J; Perera C; Zhang K; Werbovetz KA; Wang MZ
Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():27-42. PubMed ID: 35994895
[TBL] [Abstract][Full Text] [Related]
17. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD
Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447
[TBL] [Abstract][Full Text] [Related]
18. 1,4-Disubstituted-1,2,3-Triazole Compounds Induce Ultrastructural Alterations in
Almeida-Souza F; Silva VDD; Silva GX; Taniwaki NN; Hardoim DJ; Buarque CD; Abreu-Silva AL; Calabrese KDS
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961842
[TBL] [Abstract][Full Text] [Related]
19. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
20. Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.
Mwenechanya R; Kovářová J; Dickens NJ; Mudaliar M; Herzyk P; Vincent IM; Weidt SK; Burgess KE; Burchmore RJS; Pountain AW; Smith TK; Creek DJ; Kim DH; Lepesheva GI; Barrett MP
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005649. PubMed ID: 28622334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
